Jpmorgan Chase & CO Neogenomics Inc Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Neogenomics Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,219,019 shares of NEO stock, worth $17.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,219,019

Previous 979,371 24.47%

Holding current value

$17.2 Million

Previous $15.4 Million 9.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$13.01 - $15.77 $3.12 Million - $3.78 Million	239,648 Added 24.47%	1,219,019 $16.9 Million
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $2.58 Million - $3.08 Million	183,634 Added 23.08%	979,371 $15.4 Million
Q4 2023 Feb 12, 2024	SELL	$11.67 - $20.73 $3.67 Million - $6.53 Million	-314,846 Reduced 28.35%	795,737 $12.9 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $233,134 - $342,505	-19,188 Reduced 1.7%	1,110,583 $13.7 Million
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $967,316 - $1.36 Million	-68,604 Reduced 5.72%	1,129,771 $18.2 Million
Q1 2023 May 18, 2023	BUY	$9.09 - $19.45 $1.44 Million - $3.08 Million	158,281 Added 15.22%	1,198,375 $20.9 Million
Q1 2023 May 11, 2023	SELL	$9.09 - $19.45 $4.23 Million - $9.04 Million	-465,023 Reduced 30.9%	1,040,094 $18.1 Million
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $2.82 Million - $5.29 Million	437,910 Added 41.03%	1,505,117 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $6.41 Million - $10.5 Million	815,539 Added 324.05%	1,067,207 $9.19 Million
Q2 2022 Aug 11, 2022	BUY	$7.06 - $13.97 $851,548 - $1.69 Million	120,616 Added 92.04%	251,668 $2.05 Million
Q1 2022 May 11, 2022	BUY	$12.15 - $35.28 $211,543 - $614,260	17,411 Added 15.32%	131,052 $1.59 Million
Q4 2021 Feb 10, 2022	BUY	$30.49 - $48.49 $961,989 - $1.53 Million	31,551 Added 38.43%	113,641 $3.88 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $3.42 Million - $4.31 Million	82,090 New	82,090 $3.96 Million

Others Institutions Holding NEO

# of Institutions

277

Shares Held

127M

Call Options Held

581K

Put Options Held

115K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.78B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Neogenomics Inc Transaction History